by jlohrconsulting | Sep 11, 2025 | Uncategorized
PLoS Med. 2025 Sep 11;22(9):e1004740. doi: 10.1371/journal.pmed.1004740. eCollection 2025 Sep. ABSTRACT [This corrects the article DOI: 10.1371/journal.pmed.1004532.]. PMID:40934184 | DOI:10.1371/journal.pmed.1004740
by jlohrconsulting | Sep 11, 2025 | Uncategorized
PLoS One. 2025 Sep 11;20(9):e0331581. doi: 10.1371/journal.pone.0331581. eCollection 2025. ABSTRACT Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by the primary symptoms of inattention, disorganization, and/or...
by jlohrconsulting | Sep 11, 2025 | Uncategorized
Biomacromolecules. 2025 Sep 11. doi: 10.1021/acs.biomac.5c00711. Online ahead of print. ABSTRACT H2S is a very rapidly acting, highly toxic gas that can produce rapid CNS and respiratory depression. A polyethylene-glycol-incorporated polymeric sensor (NNAP-peg-P) has...
by jlohrconsulting | Sep 11, 2025 | Uncategorized
Am J Public Health. 2025 Sep 11:e1-e10. doi: 10.2105/AJPH.2025.308244. Online ahead of print. ABSTRACT Objectives. To examine the impact of Rx Kids-a community-wide and unconditional prenatal and infant cash transfer program in Flint, Michigan-on economic stability,...
by jlohrconsulting | Sep 11, 2025 | Uncategorized
JMIR Ment Health. 2025 Sep 11;12:e72038. doi: 10.2196/72038. ABSTRACT BACKGROUND: Depression is one of the most prevalent mental health disorders globally, affecting approximately 280 million people and frequently going undiagnosed or misdiagnosed. The growing...
by jlohrconsulting | Sep 11, 2025 | Uncategorized
Ecotoxicol Environ Saf. 2025 Sep 10;303:118929. doi: 10.1016/j.ecoenv.2025.118929. Online ahead of print. ABSTRACT Resmetirom, a promising oral THR-β agonist for treating metabolic dysfunction-associated steatohepatitis (MASH), has been studied extensively for its...
Recent Comments